Abstract
Both neurologic and medical complications influence outcome after stroke. Space-occupying supratentorial infarcts can cause transtentorial or uncal herniation, which leads to death. Treatments aimed at reducing intracranial pressure in patients with such infarcts are of unproven value. Mass-producing cerebellar infarction may lead to brainstem compression and obstructive hydrocephalus. These lesions often are treated surgically. Although anticonvulsants are not indicated for prophylaxis, the occurrence of epileptic seizures mandates treatment to prevent recurrences. Depression is common in the acute stage of stroke, but is probably not more prevalent after stroke than after myocardial infarction. Although dysphagia is common, it usually is a transient problem. Patients with a decrease of consciousness or brainstem dysfunction usually need tube feeding for a certain period of time. Medical complications, such as fever, infections, hyperglycemia, cardiac disorders, pressure sores, and deep venous thrombosis, are associated with a poor prognosis and should be treated as early as possible. Measures to prevent these complications are part of general care. Hypertension is very common during the week after stroke and should be treated only in case of extremely high values or malignant hypertension. A multidisciplinary approach in the stroke unit is necessary to prevent and manage complications in the acute phase of stroke.
Similar content being viewed by others
References and Recommended Reading
Hankey GJ: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2002, 16(suppl 1):14–19.
Roth EJ, Lovell L, Harvey RL, et al.: Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 2001, 32:523–529.
Langhorne P, Stott DJ, Robertson L, et al.: Medical complications after stroke: a multicenter study. Stroke 2000, 31:1223–1229.
Hacke W, Schwab S, Horn M, et al.: "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996, 53:309–315.
Hofmeijer J, van der Worp HB, Kappelle LJ: Treatment of space-occupying cerebral infarction. Crit Care Med 2003, 31:617–625.
Steiner T, Friede T, Aschoff A, et al.: Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery. Stroke 2001, 32:2833–2835.
Morley NC, Berge E, Cruz-Flores S, Whittle IR: Surgical decompression for cerebral oedema in acute ischaemic stroke. Cochrane Database Syst Rev 2002, 3:CD003435.
Hofmeijer J, van der Worp HB, Algra A, et al.: HAMLET: hemicraniectomy after MCA infarction with life-threatening edema trial. J Neurol 2003, 250(suppl 2):93.
Jauss M, Krieger D, Hornig C, et al.: Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study. J Neurol 1999, 246:257–264.
So EL, Annegers JF, Hauser WA, et al.: Population-based study of seizure disorders after cerebral infarction. Neurology 1996, 46:350–355.
Silverman IE, Restrepo L, Mathews GC: Poststroke seizures. Arch Neurol 2002, 59:195–201.
Aben I, Verhey F, Strik J, et al.: A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 2003, 74:581–585. This study shows that depression occurs equally often during the 1st year after a stroke and after myocardial infarction when controlling for nonspecific factors.
Aben I, Denollet J, Lousberg R, et al.: Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study. Stroke 2002, 33:2391–2395.
Berg A, Palomaki H, Lehtihalmes M, et al.: Poststroke depression: an 18-month follow-up. Stroke 2003, 34:138–143.
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U: Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label longterm follow up. J Neurol 2003, 250:347–351.
Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099–1104.
Ferro JM, Caeiro L, Verdelho A: Delirium in acute stroke. Curr Opin Neurol 2002, 15:51–55.
Sandberg O, Franklin KA, Bucht G, Gustafson Y: Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke. J Am Geriatr Soc 2001, 49:391–397.
Mann G, Hankey GJ, Cameron D: Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke 1999, 30:744–748.
Daniels SK, Ballo LA, Mahoney MC, Foundas AL: Clinical predictors of dysphagia and aspiration risk: outcome measures in acute stroke patients. Arch Phys Med Rehabil 2000, 81:1030–1033.
Smithard DG: Swallowing and stroke. Neurological effects and recovery. Cerebrovasc Dis 2002, 14:1–8.
Ramsey DJ, Smithard DG, Kalra L: Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 2003, 34:1252–1257.
FOOD Trial Collaboration: Poor nutritional status on admission predicts poor outcomes after stroke. Observations from the FOOD trial. Stroke 2003, 34:1450–1456.
Dawson SL, Manktelow BN, Robinson TG, et al.: Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke 2000, 31:463–468.
Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, for the IST Collaborative Group: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002, 33:1315–1320. This study demonstrates a relationship between both high and low blood pressure and poor outcome after ischemic stroke.
Semplicini A, Maresca A, Boscolo G, et al.: Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med 2003, 163:211–216.
Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056–1083. This article provides guidelines for the management of patients with ischemic stroke in the acute phase.
Rordorf G, Cramer SC, Efird JT, et al.: Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997, 28:2133–2138.
Kammersgaard LP, Jorgensen HS, Rungby JA, et al.: Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke 2002, 33:1759–1762. This study demonstrates that high body temperature on admission is a predictor of long-term mortality.
Hilker R, Poetter C, Findeisen N, et al.: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003, 34:975–981.
Reith J, Jorgensen HS, Pedersen PM, et al.: Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and oucome. Lancet 1996, 347:422–425.
Castillo J, Davalos A, Marrugat J, Noya M: Timing for feverrelated brain damage in acute ischemic stroke. Stroke 1998, 29:2455–2460.
Correia M, Silva M, Veloso M: Cooling therapy for acute stroke. Cochrane Database Syst Rev 2000, 2:CD001247.
Dippel DW, van Breda EJ, van der Worp HB, et al.: Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke. Neurology 2003, 61:677–679.
Qi R, Fineberg N, Espay A, et al.: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002, 59:67–71.
Anderson RE, Tan WK, Martin HS, Meyer FB: Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999, 30:160–170.
Capes SE, Hunt D, Malmberg K, et al.: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426–2432. A systematic review of the literature relating acute post-stroke glucose levels to the subsequent clinical course.
Kagansky N, Levy S, Knobler H: The role of hyperglycemia in acute stroke. Arch Neurol 2001, 58:1209–1212.
McDermott MM, Lefevre F, Arron M, et al.: ST segment depression detected by continuous electrocardiography in patients with acute ischemic stroke or transient ischemic attack. Stroke 1994, 25:1820–1824.
Khechinashvili G, Asplund K: Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002, 14:67–76.
Tokgozoglu SL, Batur MK, Topuoglu MA, et al.: Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999, 30:1307–1311.
Elkins JS, Sidney S, Gress DR, et al.: Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol 2002, 59:1437–1441.
Hart RG, Palacio S, Pearce LA: Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 2002, 33:2722–2727.
Muir KW, Watt A, Baxter G, et al.: Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Q J Med 2000, 93:359–364.
Amarigiri SV, Lees TA: Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000, 3:CD001484.
Brittain KR, Peet SM, Castleden CM: Stroke and incontinence. Stroke 1998, 29:524–528.
Dennis M: Nutrition after stroke. Br Med Bull 2000, 56:466–475.
Davenport RJ, Dennis MS, Warlow CP: Gastrointestinal hemorrhage after acute stroke. Stroke 1996, 27:421–424.
Stroke Unit Trialists’ Collaboration: Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997, 314:1151–1159.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kappelle, L.J., van der Worp, H.B. Treatment or prevention of complications of acute ischemic stroke. Curr Neurol Neurosci Rep 4, 36–41 (2004). https://doi.org/10.1007/s11910-004-0009-5
Issue Date:
DOI: https://doi.org/10.1007/s11910-004-0009-5